, Author at AAPM - Page 76 of 85

Number of Opioid Prescriptions Remains Unchanged, Mayo Clinic Research Finds

Source: Mayo Clinic Despite increased attention to opioid abuse, prescriptions have remained relatively unchanged for many U.S. patients, research led by Mayo Clinic and published in The BMJ.Full story.

Opioid Prescribing Decreases after Learning of a Patient’s Fatal Overdose

Source: PubMed.govRead the abstract.

Study Finds Racial Disparities in Prescribing Opioids for Chronic Pain

Source: Yale News Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain. Black patients who receive opioids long-term are more likely than whites to be tested [...]

Poorest Americans Most Likely to Have Used Prescription Opioids — and Most Users View Opioids Positively

Source: University at Buffalo University at Buffalo study raises important questions about access to pain management options for the disadvantaged in the current climate of the opioid epidemic.Full story.

A Before and After Analysis of Health Care Utilization by Patients Enrolled in Opioid Controlled Substance Agreements for Chronic Noncancer Pain

Source: Mayo ClinicRead the abstract.

Students Learn to Treat Pain, With and Without Opioids

Source: AAMCNews As the opioid epidemic claims even more lives, medical schools are rethinking how they teach students to manage patients' pain. The result? A better understanding of the nature of pain, addiction, and substance [...]

Nonaddictive Drug Compound Could Replace Opioids for Chronic Pain Sufferers

Source: Purdue University A compound shows unparalleled selectivity in inhibiting the adenylyl cyclase 1 (AC1), making it a potential target for treating pain and reducing the dependency on opioids for pain management.Full story.

Gabapentinoid Use in the United States 2002 through 2015 (Research Letter)

Source: JAMA Internal Medicine Gabapentin and pregabalin are the 2 clinically used medications in the gabapentinoid drug class. Pregabalin and gabapentin have both been approved by the US Food and Drug Administration for treatment of [...]